Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*

By Philip E. Cryer. Diabetologia, 2002

837 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/ebdcc733bdd208ee1005932d38511abefb8034d6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. V. Basevi
2. R. Bergenstal
3. P. Cryer
4. Silvio E. Inzucchi
5. I. Hirsch
6. K. ‐. Tseng
7. M. S. Kirkman
8. A. Classification

In Surgery

1. V. Basevi
2. P. Cryer
3. Silvio E. Inzucchi
4. I. Hirsch
5. K. ‐. Tseng
6. M. S. Kirkman
7. A. Classification

Citations in the corpus

• Standards of Medical Care in Diabetes—2014 (2013, background): “Hypoglycemia is the leading limiting factor in the glycemic management of type 1 and insulin-treated type 2 diabetes (289).”
• Standards of Medical Care in Diabetes—2008 (2008, background): “Preventing hypoglycemia Hypoglycemia, especially in insulintreated patients, is the leading limiting factor in the glycemic management of type 1 and type 2 diabetes (117).”
• Standards of Medical Care in Diabetes—2009 (2009, background): “Hypoglycemia is the leading limiting factor in the glycemic management of type 1 and insulin-treated type 2 diabetes (146).”
• Standards of Medical Care in Diabetes—2012 (2011, background): “Hypoglycemia, especially in insulin-treated patients, is the leading limiting factor in the glycemic management of type 1 and type 2 diabetes (165).”
• Standards of Medical Care in Diabetes–2006 (2006, background): “Preventing hypoglycemia Hypoglycemia, especially in insulintreated patients, is the leading limiting factor in the glycemic management of type 1 and type 2 diabetes (93).”
• Standards of Medical Care in Diabetes—2013 (2012, background): “Hypoglycemia is the leading limiting factor in the glycemic management of type 1 and insulin-treated type 2 diabetes (223).”
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2012, background): “as normal a glycaemic profile as possible without unacceptable weight gain or hypoglycaemia [73].”
• Hypoglycemia in diabetes. (2003, background): “Pending the prevention and cure of diabetes, people with diabetes need treatment methods that provide glucoseregulated insulin replacement or secretion if they are to consistently achieve and maintain euglycemia safely (1).”
• Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. (2005, neutral): “Hypoglycemia The desire to avoid hypoglycemia is one of the major barriers to achieving nearnormal glycemic control (113).”